BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16341812)

  • 61. Muir-Torre syndrome.
    Lachiewicz AM; Wilkinson TM; Groben P; Ollila DW; Thomas NE
    Am J Clin Dermatol; 2007; 8(5):315-9. PubMed ID: 17902735
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cancer risks and immunohistochemical profiles linked to the Danish MLH1 Lynch syndrome founder mutation.
    Therkildsen C; Isinger-Ekstrand A; Ladelund S; Nissen A; Rambech E; Bernstein I; Nilbert M
    Fam Cancer; 2012 Dec; 11(4):579-85. PubMed ID: 22864660
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Muir-Torre syndrome and HNPCC: importance of clinical diagnosis and genetic investigation in family members].
    Strul H; Rozen P; Naiman T; Shomrat R
    Harefuah; 1999 Feb; 136(4):274-6, 339. PubMed ID: 10914216
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Hereditary colon cancer in Lynch syndrome/HNPCC syndrome in Germany].
    Büttner R; Friedrichs N
    Pathologe; 2019 Nov; 40(6):584-591. PubMed ID: 31372733
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma.
    Dove-Edwin I; Boks D; Goff S; Kenter GG; Carpenter R; Vasen HF; Thomas HJ
    Cancer; 2002 Mar; 94(6):1708-12. PubMed ID: 11920532
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Neurofibromatosis von Recklinghausen type I phenotype and early onset of cancers in siblings compound heterozygous for mutations in MSH6.
    Ostergaard JR; Sunde L; Okkels H
    Am J Med Genet A; 2005 Dec; 139A(2):96-105; discussion 96. PubMed ID: 16283678
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Genetic testing of children at risk for adult onset conditions: when is testing indicated?
    Lwiwski N; Greenberg CR; Mhanni AA
    J Genet Couns; 2008 Dec; 17(6):523-5. PubMed ID: 18607700
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The great mimicker: Phenotypic overlap between constitutional mismatch repair deficiency and Tuberous Sclerosis complex.
    Shapira Rootman M; Goldberg Y; Cohen R; Kropach N; Keidar I; Friedland R; Dotan G; Konen O; Toledano H
    Clin Genet; 2020 Feb; 97(2):296-304. PubMed ID: 31730237
    [TBL] [Abstract][Full Text] [Related]  

  • 69. SISE matters: the sum of information on seventy-yr-old equivalents measures pedigree information content when assessing the risk of HNPCC in a family.
    Green RC; McLaughlin JR; Younghusband HB
    Fam Cancer; 2005; 4(2):169-75. PubMed ID: 15951969
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Probable involvement of a germ-line mutation of an unknown mismatch repair gene in a Japanese Muir-Torre syndrome phenotype.
    Kubota T; Dakeishi M; Nozaki J; Manabe M; Koizumi A
    J Dermatol Sci; 2000 Jun; 23(2):117-25. PubMed ID: 10808129
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Constitutional mismatch repair deficiency syndrome: Do we know it?
    Ramachandra C; Challa VR; Shetty R
    Indian J Hum Genet; 2014 Apr; 20(2):192-4. PubMed ID: 25400351
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Gynecologic cancers associated with Lynch syndrome/HNPCC.
    Schmeler KM; Lu KH
    Clin Transl Oncol; 2008 Jun; 10(6):313-7. PubMed ID: 18558577
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ovarian cancer risk is associated with a common variant in the promoter sequence of the mismatch repair gene MLH1.
    Harley I; Rosen B; Risch HA; Siminovitch K; Beiner ME; McLaughlin J; Sun P; Narod SA
    Gynecol Oncol; 2008 Jun; 109(3):384-7. PubMed ID: 18405947
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Analysis for phenotype of HNPCC in China.
    Song YM; Zheng S
    World J Gastroenterol; 2002 Oct; 8(5):837-40. PubMed ID: 12378626
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Clinical features and mutation analysis of a poly-(A)8 tract in M3 cholinergic receptor gene in Chinese HNPCC families].
    Cao WM; Yuan Y; Song YM; Cai SR; Zhang SZ
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 33(5):399-402. PubMed ID: 15476321
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Lynch Syndrome-Associated Cancers Beyond Colorectal Cancer.
    Biller LH; Creedon SA; Klehm M; Yurgelun MB
    Gastrointest Endosc Clin N Am; 2022 Jan; 32(1):75-93. PubMed ID: 34798988
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cancer risk in Lynch Syndrome.
    Barrow E; Hill J; Evans DG
    Fam Cancer; 2013 Jun; 12(2):229-40. PubMed ID: 23604856
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Position paper: Challenges and specific strategies for constitutional mismatch repair deficiency syndrome in low-resource settings.
    Kebudi R; Amayiri N; Abedalthagafi M; Rana AN; Kirmani S; Musthaq N; Lamki ZA; Houdzi JE; Yazici H; El-Naggar S; Edwards M; Bianchi VJ; Durno C; Tabori U; Bouffet E;
    Pediatr Blood Cancer; 2020 Aug; 67(8):e28309. PubMed ID: 32472748
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Phenotypic variation in hereditary nonpolyposis colon cancer syndrome. Association with infiltrative fibromatosis (desmoid tumor).
    Maher ER; Morson B; Beach R; Hodgson SV
    Cancer; 1992 Apr; 69(8):2049-51. PubMed ID: 1544113
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Non-Hodgkin's lymphoma in a patient with probable hereditary nonpolyposis colon cancer: report of a case and review of the literature.
    Hirano K; Yamashita K; Yamashita N; Nakatsumi Y; Esumi H; Kawashima A; Ohta T; Mai M; Minamoto T
    Dis Colon Rectum; 2002 Feb; 45(2):273-9. PubMed ID: 11852345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.